Skip to content

Nationalwide skin cancer screening using artificial intelligence

Implementation of Nationwide Skin Cancer Screening Platform using Artificial Intelligence technology

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20211101004
Enrollment
597
Registered
2021-11-01
Start date
2023-10-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin cancer patients, including melanoma, basal cell carcinoma and squamous cell carcinoma artificial intelligence, machine learning, melanoma, pigmented skin lesions, skin cancer screening

Interventions

1. Teledermatology system including information from - Sub-district health promoting hospital personnel (skin lesion images, text history, patients&#039
awareness) - central dermatologists (spot diagnosis with up to 2 differential diagnoses, level of confidence, recommendation for next step of management) - local dermatologist, in case of referral (ty
Experimental Device,No Intervention No treatment
Nationwide Skin Cancer Screening Platform using Teledermatology and Artificial Intelligence technology (STAT),Standard of care

Sponsors

Thailand Science Research and Innovation
Lead Sponsor
Institute of Dermatology
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Male or female patents Age more than 18 years old Who has skin lesion(s) that is suspected for skin cancer and visits the Sub-district Health Promoting Hospitals of 1st-12th Area Health in Thailand.

Exclusion criteria

Exclusion criteria: The patient who was once diagnosed skin cancer. The suspected skin lesion(s) is located in the area that is difficult to be shot by the camera, such as ear canals, nasal canals, intraorbital area, vagina or rectum. The patient doesn't give an informed consent for photo shooting.

Design outcomes

Primary

MeasureTime frame
numbers and percentage of system-assisted referred patients 18 months after the beginning of the study number and percentage of patients

Secondary

MeasureTime frame
Patient's self awareness about skin cancer 18 months after the beginning of the study ratio of number of patients that have self awareness / patients that neglect about the existing skin cancer lesions

Countries

Thailand

Contacts

Public ContactOnjuta Chayangsu

Institute of Dermatology

info@inderm.go.th023545222

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026